Krystal Biotech, Inc. (KRYS) Operating income 2016–2025
Krystal Biotech, Inc. (KRYS) annual operating income history from SEC filings — each fiscal year as reported.
$161.3MFY2025 · since FY2016: -$1.1M → $161.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $161.3M | +145.3% |
| FY2024 | $65.7M | +160.0% |
| FY2023 | -$109.6M | +24.5% |
| FY2022 | -$145.2M | -112.7% |
| FY2021 | -$68.3M | -106.9% |
| FY2020 | -$33.0M | -49.4% |
| FY2019 | -$22.1M | -85.3% |
| FY2018 | -$11.9M | -149.7% |
| FY2017 | -$4.8M | -317.5% |
| FY2016 | -$1.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KRYS financial trends
KRYS RevenueKRYS Net incomeKRYS Net marginKRYS Gross profitKRYS Gross marginKRYS Operating marginKRYS Operating cash flowKRYS Free cash flowKRYS Capital expendituresKRYS Return on equityKRYS Stock buybacksKRYS Dividends paidKRYS Total assetsKRYS Total liabilitiesKRYS Shareholders’ equityKRYS overview →